Revolution Medicines Inc   (RVMD)

News about Revolution Medicines Inc

Revolution Medicines Unveils RMC-6236: Transforming Cancer Treatment with a Breakthrough RAS(ON) Inhibitor.
Apr 09 2024
Revolution Medicines, a leading biotechnology company at the forefront of cancer research, has recently announced a groundbreaking discovery in the fi...

Revolution Medicines Unveils Groundbreaking RAS Inhibitor with Unprecedented Anti-Tumor Activity in Pancreatic Cancer Models
Apr 08 2024
Revolution Medicines Announces Groundbreaking Discovery and Preclinical Profile of New Class of RAS(ON) Multi-Selective Inhibitors with Unprecedented ...

Revolution Medicines Inc Reports Increased Deficit in Recent Fiscal Period; Promising Clinical Data Ignites Hope for Future Performance
Nov 07 2023
Revolution Medicines Inc Reports Increased Deficit in Recent Fiscal Period, But Encouraging Clinical Data Fuels Optimism for Future PerformanceIn...

The Losses have enlarged even more at the company in fiscal time-frame closing June 30 2023
Aug 09 2023
Revolution Medicines Inc, a pharmaceutical company trading on the NASDAQ, has experienced a notable stock improvement of 6.47% over the past...

Revolution Medicines Inc Struggles with Steep Decline in Revenue, Poses Worries for Investors
May 09 2023
Investors in Revolution Medicines Inc (RVMD) may be feeling concerned about the company*s future prospects after it reported a significant loss in its...

The Biotechnology & Pharmaceuticals company disclosed a loss despite very impressive 62.051%, revenue rise, in the fiscal fourth quarter of 2022
May 09 2023

The Diminishing Returns have widen more at RVMD in the third quarter of 2022
May 09 2023


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com